ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Impact of a standardized management protocol and antimicrobial stewardship intervention on mortality and quality of care in Staphylococcus aureus bacteremia: a before-after study.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeStaphylococcus aureus bacteremia (SAB) is associated with substantial morbidity and mortality. This study aimed to evaluate changes in quality-of-care indicators and clinical outcomes following implementation of a standardized SAB management protocol combined with an antimicrobial stewardship intervention.
methodsThis single-center, quasi-experimental before-and-after study included adult patients with SAB. Patients diagnosed in 2024 constituted the pre-intervention cohort, whereas those assessed between January and September 2025 constituted the post-intervention cohort. During the post-intervention period, cases were proactively evaluated at the bedside by infectious diseases specialists following laboratory notification, using a structured checklist addressing follow-up blood cultures, echocardiography, source assessment and control, and definitive antimicrobial agent selection.
resultsOverall, 143 patients were included: 88 in the pre-intervention and 55 in the post-intervention cohort. Baseline characteristics and measured indicators of disease severity and infection complexity were comparable between groups. Adherence to the minimum evaluation bundle increased from 47.7% to 69.1% (p = 0.012), echocardiographic evaluation from 65.9% to 92.7% (p < 0.001), follow-up blood cultures obtained within 24-48 h from 36.4% to 72.7% (p < 0.001), and guideline-concordant definitive antimicrobial agent selection from 65.9% to 87.3% (p = 0.005). Seven-day mortality was 13.6% in the pre-intervention cohort and 3.6% in the post-intervention cohort (p = 0.050), while 28-day mortality was 33.0% and 16.4%, respectively (p = 0.029). In the multivariable Cox proportional hazards model, the post-intervention period was associated with a lower hazard of 28-day mortality (adjusted HR 0.46, 95% CI 0.22-0.97; p = 0.040), whereas higher Charlson Comorbidity Index (adjusted HR 1.17 per point, 95% CI 1.04-1.31; p = 0.008) and ICU admission (adjusted HR 4.10, 95% CI 2.14-7.81; p < 0.001) were associated with higher mortality.
conclusionImplementation of a standardized, infectious diseases-led SAB management protocol incorporating antimicrobial stewardship was associated with improved quality-of-care processes and lower 28-day mortality. These findings support the potential clinical value of a structured, proactive approach to SAB management, although the before-and-after design precludes causal inference.
Indexed as
Identifiers
42640390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.